Human adipose stem cell conditioned medium has a pro-fibrotic and EMT-stimulating effect on urethral fibroblasts in vitro.
Barasa P., Baltrukonyte E., Simoliune I., Grybas A., Baltriukiene D.
Laboratory Study on Scar, Chronic Inflammation, published in Eur J Cell Biol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Eur J Cell Biol (2026)
- Country
- Germany
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41996833
- DOI
- 10.1016/j.ejcb.2026.151538
Abstract (original English)
Fibrosis, characterized by excessive deposition of scar tissue, leads to the dysfunction of various organs. An urethral stricture, or pathological narrowing of the urethra, is an example of such scarring. The use of human adipose stem cell conditioned medium (HASC-CM) has shown promise as an anti-fibrotic treatment in vivo, as molecules produced by HASCs exhibit anti-inflammatory and fibrosis-modulating properties. However, HASC-CM has also been demonstrated to activate epithelial-to-mesenchymal transition (EMT) in cancer-associated cells. To elucidate whether HASC-CM promotes EMT or myofibroblast activation, we investigated its effects on primary human urethral fibroblasts (HUFs) and prostatic fibroblasts of the WPMY-1 line. We showed that HASC-CM promotes migration speed in HUFs but not in WPMY-1 cells while also increasing vimentin levels in the cells, both markers of EMT. Moreover, HASC-CM suppressed SMAD5 signalling in HUFs without altering SMAD3 signalling in either cell type. In addition, HASC-CM treatment induced myocardin-related transcription factor A (MRTF-A) nuclear translocation and increased amount of alpha smooth muscle actin (αSMA) in HUFs, indicating a shift towards the myofibroblast phenotype. We conclude that the effect of HASC-CM on WPMY-1 cells is negligible, however, this type of treatment has a pro-fibrotic and EMT-stimulating effect on HUFs.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level AMeta-analysisPubMed
Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 323 on Scar, published in Eur J Obstet Gynecol Reprod Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 323
Eur J Obstet Gynecol Reprod Biol - Level AMeta-analysisEurope PMC
Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis
Meta-analysis on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewEurope PMC
Comparative Efficacy and Safety of Fractional CO<sub>2</sub> Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review
Systematic Review on Chronic Wound, Scar, published in Skin Res Technol (2026) — summary generated from the PubMed abstract.
- 2026
Skin Res Technol - Level AMeta-analysisPubMed
Role of exosome therapy in reconstructive surgery: a review.
Meta-analysis on Chronic Wound, Scar, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne)1 citations